Skip to content
All Podcasts – Lifestyle
Author:
ProBio Inc.
ProBio Enters Exclusive Global Licensing Agreement with AbTis to Develop Next-Generation ADC Asset
November 10, 2026
ProBio Successfully Completes NMPA Pre-Approval Inspection for Biologics Manufacturing Facility in Nanjing, China
October 21, 2026
ProBio and Kun Tuo Announce Strategic Collaboration to Deliver Integrated CDMO-CRO Solutions for Advanced Therapies
September 16, 2026
ProBio’s AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class pan-cancer CAR‑T Program
July 1, 2026
ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China
June 3, 2026